Home › NDC Lookup › RxCUI directory › RxCUI 2709612

Sitagliptin phosphate 25 MG Oral Tablet — RxCUI 2709612

RxNorm drug concept · Semantic clinical drug
RxCUI 2709612 Semantic clinical drug · SCD ● Current RxNorm concept 12 FDA products 33 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2709612
Official nameSitagliptin phosphate 25 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped12
Package NDCs mapped33
Reported Medicaid activity (SDUD)677,787 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Sitagliptin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Sitagliptin helps your body manage blood sugar more effectively by keeping certain gut hormones active longer after you eat. Those hormones tell your pancreas to release more insul...
  • What exactly does sitagliptin do — and will it cure my diabetes?
  • On its own, sitagliptin is very unlikely to cause low blood sugar — that's actually one of its advantages. The reason is that it only kicks in when your blood sugar is already elev...
  • Can sitagliptin make my blood sugar go too low?
📖 Read our full Sitagliptin guide →

🕸️ Concept Web — How Sitagliptin phosphate 25 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Sitagliptin phosphate 25 MG Oral Tablet RxCUI 2709612

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Sitagliptin 593411
    • Sitagliptin phosphate 621590
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Januvia 638596
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Sitagliptin Oral Tablet 665032
    • Sitagliptin phosphate Oral Tablet 2709602
    • Sitagliptin Oral Product 1159662
    • Sitagliptin Pill 1159663
    • Sitagliptin phosphate Oral Product 2709600
    • Sitagliptin phosphate Pill 2709601
    • Sitagliptin Oral Tablet [Januvia] 665035
    • Sitagliptin phosphate Oral Tablet [Januvia] 2709605
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Sitagliptin phosphate 25 MG SCDC · 2709611
  • Sitagliptin Oral Tablet SCDF · 665032
  • Sitagliptin phosphate Oral Tablet SCDFP · 2709602
  • Sitagliptin Oral Product SCDG · 1159662
  • Sitagliptin Pill SCDG · 1159663
  • Sitagliptin phosphate Oral Product SCDGP · 2709600
  • Sitagliptin phosphate Pill SCDGP · 2709601

Brand-Name Concepts

  • Sitagliptin phosphate 25 MG Oral Tablet [Januvia] SBD · 665040
  • Sitagliptin phosphate 25 MG [Januvia] SBDC · 2709613
  • Sitagliptin Oral Tablet [Januvia] SBDF · 665035
  • Sitagliptin phosphate Oral Tablet [Januvia] SBDFP · 2709605
  • Januvia Oral Product SBDG · 1167814
  • Januvia Pill SBDG · 1167815
  • Januvia BN · 638596

📦 FDA Products & Package NDCs

12 products · 33 package NDCs
33 package NDCs map to RxCUI 2709612 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00006-0112-28 100 BLISTER PACK in 1 CARTON (0006-0112-28) / 1 TABLET, FIL... JANUVIA Merck Sharp & Dohme LLC 2006-10-16
00006-0112-31 30 TABLET, FILM COATED in 1 BOTTLE (0006-0112-31) JANUVIA Merck Sharp & Dohme LLC 2006-10-16
00006-0112-54 90 TABLET, FILM COATED in 1 BOTTLE (0006-0112-54) JANUVIA Merck Sharp & Dohme LLC 2006-10-16
00006-0221-28 100 BLISTER PACK in 1 CARTON (0006-0221-28) / 1 TABLET, FIL... JANUVIA Merck Sharp & Dohme LLC 2006-10-16
00006-0221-31 30 TABLET, FILM COATED in 1 BOTTLE (0006-0221-31) JANUVIA Merck Sharp & Dohme LLC 2006-10-16
00006-0221-54 90 TABLET, FILM COATED in 1 BOTTLE (0006-0221-54) JANUVIA Merck Sharp & Dohme LLC 2006-10-16
00006-0277-02 30 TABLET, FILM COATED in 1 DOSE PACK (0006-0277-02) JANUVIA Merck Sharp & Dohme LLC 2006-10-16
00006-0277-14 2 BLISTER PACK in 1 CARTON (0006-0277-14) / 7 TABLET, FILM... JANUVIA Merck Sharp & Dohme LLC 2012-10-12
00006-0277-28 100 BLISTER PACK in 1 CARTON (0006-0277-28) / 1 TABLET, FIL... JANUVIA Merck Sharp & Dohme LLC 2006-10-16
00006-0277-31 30 TABLET, FILM COATED in 1 BOTTLE (0006-0277-31) JANUVIA Merck Sharp & Dohme LLC 2006-10-16
00006-0277-33 30 TABLET, FILM COATED in 1 DOSE PACK (0006-0277-33) JANUVIA Merck Sharp & Dohme LLC 2006-10-16
00006-0277-54 90 TABLET, FILM COATED in 1 BOTTLE (0006-0277-54) JANUVIA Merck Sharp & Dohme LLC 2006-10-16
00006-0277-82 1000 TABLET, FILM COATED in 1 BOTTLE (0006-0277-82) JANUVIA Merck Sharp & Dohme LLC 2006-10-16
00480-2607-56 30 TABLET, FILM COATED in 1 BOTTLE (0480-2607-56) Sitagliptin Teva Pharmaceuticals, Inc. 2026-05-28
00480-2607-98 90 TABLET, FILM COATED in 1 BOTTLE (0480-2607-98) Sitagliptin Teva Pharmaceuticals, Inc. 2026-05-28
00480-2608-56 30 TABLET, FILM COATED in 1 BOTTLE (0480-2608-56) Sitagliptin Teva Pharmaceuticals, Inc. 2026-05-28
00480-2608-98 90 TABLET, FILM COATED in 1 BOTTLE (0480-2608-98) Sitagliptin Teva Pharmaceuticals, Inc. 2026-05-28
00480-2609-10 1000 TABLET, FILM COATED in 1 BOTTLE (0480-2609-10) Sitagliptin Teva Pharmaceuticals, Inc. 2026-05-28
00480-2609-56 30 TABLET, FILM COATED in 1 BOTTLE (0480-2609-56) Sitagliptin Teva Pharmaceuticals, Inc. 2026-05-28
00480-2609-98 90 TABLET, FILM COATED in 1 BOTTLE (0480-2609-98) Sitagliptin Teva Pharmaceuticals, Inc. 2026-05-28
00781-5766-31 30 TABLET, FILM COATED in 1 BOTTLE (0781-5766-31) Sitagliptin Phosphate Sandoz Inc 2026-01-14
00781-5766-92 90 TABLET, FILM COATED in 1 BOTTLE (0781-5766-92) Sitagliptin Phosphate Sandoz Inc 2026-01-14
00781-5768-31 30 TABLET, FILM COATED in 1 BOTTLE (0781-5768-31) Sitagliptin Phosphate Sandoz Inc 2026-01-14
00781-5768-92 90 TABLET, FILM COATED in 1 BOTTLE (0781-5768-92) Sitagliptin Phosphate Sandoz Inc 2026-01-14
00781-5770-10 1000 TABLET, FILM COATED in 1 BOTTLE (0781-5770-10) Sitagliptin Phosphate Sandoz Inc 2026-01-14
00781-5770-31 30 TABLET, FILM COATED in 1 BOTTLE (0781-5770-31) Sitagliptin Phosphate Sandoz Inc 2026-01-14
00781-5770-92 90 TABLET, FILM COATED in 1 BOTTLE (0781-5770-92) Sitagliptin Phosphate Sandoz Inc 2026-01-14
60505-3643-03 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60505-3643-3) Sitagliptin Apotex Corp. 2026-05-28
60505-3643-09 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60505-3643-9) Sitagliptin Apotex Corp. 2026-05-28
60505-3644-03 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60505-3644-3) Sitagliptin Apotex Corp. 2026-05-28
60505-3644-09 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60505-3644-9) Sitagliptin Apotex Corp. 2026-05-28
60505-3645-03 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60505-3645-3) Sitagliptin Apotex Corp. 2026-05-28
60505-3645-09 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60505-3645-9) Sitagliptin Apotex Corp. 2026-05-28
Observed labelers: Merck Sharp & Dohme LLC (13) · Sandoz Inc (7) · Teva Pharmaceuticals, Inc. (7) · Apotex Corp. (6) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.